3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
34
Colonic Neoplasms
18
Rectal Neoplasms
14
Pancreatic Neoplasms
8
Esophageal Neoplasms
7
Adenomatous Polyposis Coli
7
Liver Neoplasms
5
Carcinoma, Hepatocellular
4
Neoplasm Metastasis
3
Turcot syndrome
2
Thymoma
2
Neoplasms
2
Lung Neoplasms
2
Locally Advanced Rectal Cancer
2
Hand-Foot Syndrome
2
Gastrointestinal Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Breast Neoplasms
2
Adenocarcinoma Of Esophagus
2
Thrombocytosis
1
Stomach Neoplasms
1
Sarcoma
1
Recurrence
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Polyps
1
Pancreatic Cancer Metastatic
1
Pain, Postoperative
1
Interventions
Pancreaticojejunostomy
4
Endoscopic Mucosal Resection
3
Octreotide
2
obeticholic acid
1
fludarabine
1
apixaban
1
aldesleukin
1
X-Rays
1
Ursodeoxycholic Acid
1
Tranexamic Acid
1
Tissue Adhesives
1
Tea
1
Surgical Procedures, Operative
1
Stents
1
Specimen Handling
1
Sodium Chloride
1
Rivaroxaban
1
Radiotherapy
1
Radiosurgery
1
Phantoms, Imaging
1
Pantoprazole
1
Nutritional Status
1
Nutrition Therapy
1
Irinotecan
1
Iopamidol
1
Hydromorphone
1
Hydrocortisone
1
High-Energy Shock Waves
1
Epinephrine
1
Enteral Nutrition
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Duodenal Neoplasms
×
Celecoxib
×
Gastrointestinal
×
Clear all
NCT00808743
2013-05-16
PreDuoFAP
Radboud University Medical Center
Phase 2/3
Completed
37 enrolled